Consequently, the international Kidney Disease Improving Global Outcomes (KDIGO) guidelines (2017) for CKD-MBD suggest maintaining serum calcium, phosphate, and PTH within normal ranges to reduce the high mortality risk in these patients, although more research about these and other MBD biomarkers is encouraged [5]. Here, PTH is linked to Marchiafava-Bignami disease.